Comparison and interpretability of the available urticaria activity scores

by mm-red | Jul 29, 2020

The urticaria activity score (UAS) is the gold standard for assessing disease activity in patients with chronic spontaneous urticaria (CSU). Two different versions, the UAS7 and UAS7TD, are currently used in clinical trials and routine care. To compare both versions...

Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema

by mm-red | Jun 25, 2020

Purpose of review: The aim of this review is to highlight the most important, clinically relevant patient-reported outcome (PRO) measures for chronic spontaneous urticaria and recurrent angioedema. Recent findings: The use of PROs becomes increasingly important in...

Instrumente zur Erfassung von Krankheitsaktivität, Krankheitskontrolle und Lebensqualitätsbeeinträchtigung bei Patienten mit chronischer Urtikaria und Angioödemen

by mm-red | Jun 23, 2020

Clinical measures of chronic urticaria

by mm-red | Jun 23, 2020

The urticaria activity score – validity, reliability, and responsiveness

by mm-red | Jun 13, 2020

BACKGROUND: Chronic spontaneous urticaria is characterized by fluctuating symptoms. Its activity is assessed with the urticaria activity score (UAS). Two versions of the urticaria activity score used for 7 consecutive days (UAS7) are available: (1) The...